Geode Capital Management, LLC Cytokinetics Inc Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,994,445 shares of CYTK stock, worth $142 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,994,445
Previous 2,937,484
1.94%
Holding current value
$142 Million
Previous $118 Million
16.2%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding CYTK
# of Institutions
369Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$837 Million0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$698 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$570 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$372 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$303 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.48B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...